Article info
Colon cancer
Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer
- Correspondence to Dr François Ghiringhelli, Georges-Francois Leclerc Cancer Centre, INSERM Avenir 866, 1 rue du Professeur Marion, Dijon 21000, France; fghiringhelli{at}dijon.fnclcc.fr
Citation
Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer
Publication history
- Revised September 2, 2009
- Accepted September 16, 2009
- First published October 15, 2009.
Online issue publication
March 05, 2010
Article Versions
- Previous version (15 October 2009).
- Previous version (16 October 2009).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited For permission to use, (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.